The stock of SeaSpine Holdings Corp (NASDAQ:SPNE) reached all time low today, Nov, 24 and still has $6.59 target or 5.00% below today’s $6.94 share price. This indicates more downside for the $78.43 million company. This technical setup was reported by Barchart.com. If the $6.59 PT is reached, the company will be worth $3.92 million less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only. The stock decreased 1.70% or $0.12 on November 23, hitting $6.94. About 67,973 shares traded hands or 94.74% up from the average. SeaSpine Holdings Corp (NASDAQ:SPNE) has declined 51.67% since April 22, 2016 and is downtrending. It has underperformed by 57.08% the S&P500.
Analysts await SeaSpine Holdings Corp (NASDAQ:SPNE) to report earnings on March, 21. They expect $-0.36 earnings per share, up 70.73% or $0.87 from last year’s $-1.23 per share. After $-0.84 actual earnings per share reported by SeaSpine Holdings Corp for the previous quarter, Wall Street now forecasts -57.14% EPS growth.
According to Zacks Investment Research, “SeaSpine Holdings Corporation is a medical technology company which focused on the design, development and commercialization of surgical solutions for the treatment of spinal disorders. The company also offers orthobiologics and spinal fusion hardware solutions. SeaSpine Holdings Corporation is headquartered in Vista, California.”
More news for SeaSpine Holdings Corp (NASDAQ:SPNE) were recently published by: Quotes.Wsj.com, which released: “News SeaSpine Holdings Corp.SPNE” on June 27, 2015. Streetinsider.com‘s article titled: “Form 4 SeaSpine Holdings Corp For: Nov 18 Filed by: Valentine Keith” and published on November 21, 2016 is yet another important article.
SPNE Company Profile
SeaSpine Holdings Corporation, incorporated on February 12, 2015, is a medical technology company. The Firm is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Firm operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. The Firm has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.